Prestige BioPharma Limited

KSE:950210.KS

18670 (KRW) • At close July 4, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) KRW.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q4
Operationele Activiteiten:
Nettowinst -21,895.756-10,477.675-13,055.824-1,447.792-13,027.978-17,032.206-15,333.113-22,138.633-19,014.85753,627.837-101,309.789-85,958.054-14,011.632-10,170.6622,581.8-9,707.58135.516-400.672-6,788.282
Afschrijvingen & Amortisatie 0004,478.7923,841.7923,414.9283,415.6473,263.9923,146.9311,800.1861,181.812955.456964.046782.583539.794000520.934
Uitgestelde Inkomstenbelasting 00000000000000-11,445.5730000
Aandelen Gebaseerde Vergoedingen 00000000000000368.6880000
Verandering in Werkkapitaal 00000000000000-1,320.585000-9,884.741
Vorderingen 00000000000000931.8840000
Voorraden 0000000000000000000
Crediteuren 000000000000001,014.3170000
Overig Werkkapitaal 00000000000000-3,264.5420000
Overige Niet-Contante Posten -2,475.421-9,640.369-364.936-4,928.479-2,336.0911,339.294-12,875.9116,809.893-2,221.323-70,754.63689,136.36760,280.4091,025.35513,918.938398.52410,701.755-9,908.8732,610.8034,473.716
Kasstroom uit Operationele Activiteiten -24,371.177-20,118.044-13,420.76-10,855.063-11,522.276-12,277.984-24,793.376-2,064.748-18,089.249-15,326.613-10,991.61-25,677.645-12,986.2773,748.276-8,877.352994.175-9,773.3572,210.131-11,678.373
Investeringsactiviteiten:
Investeringen in Materiële Vaste Activa 2,439.725-14,195.844-5,298.24-6,925.631-6,237.368-8,074.221-8,911.821-23,113.946-19,635.718-13,955.197-14,184.835-10,333.325-22,455.856-21,138.619-3,114.48-5,138.716-3,291.007-6,567.233-727.701
Netto Overnames 000-0.469-18.17369.943-72.984-35.558316.74239,830.4029,671.7716,816.320000000
Aankoop van Beleggingen -32,574.18-19,794000-69.943-133,690.599000-412.086-20,714.171-2,040.97-2,072.18900000
Verkoop/verval van Beleggingen 0023,026.164301.267134,822.1351,722.688133,690.599000-9,671.7700000000
Overige Investeringsactiviteiten -1,172.898-924.723-998.36921.1672,733.766-2,591.889-124,765.105958.638499.733274.56215,337.924-76,023.128-23,975.765-14,051.688-2,963.281-757.6171,034.766-114.792,205.041
Kasstroom uit Investeringsactiviteiten -31,307.353-34,914.56716,729.555-6,603.667131,300.359-8,943.422-133,749.91-22,190.866-18,819.24326,149.767741.003-107,070.624-45,459.552-32,896.077-6,077.761-5,896.333-2,256.241-6,682.0231,477.34
Financieringsactiviteiten:
Schuldaflossingen 32,574.1819,7942.13-269.989-3,161.0672,608.32410,990.53644,444.615-268.447-270.309-47.591-26.67134.247-2,874.8082,340.565435.66414.968-509.892-107.72
Uitgifte van Gewone Aandelen 00-4.908877.258436.46600000000014,576.4490000
Terugkoop van Gewone Aandelen 0000000000000000000
Uitgekeerde Dividenden 0000000000000000000
Overige Financieringsactiviteiten -151.384-521.637-501.239-492.623-487.433-475.838-479.1-413.184-429.149-391.584-431.847-409.616-482.487-264.733-13,551.122452,212.169-112.264-99.634-1,450.138
Kasstroom uit Financieringsactiviteiten 32,422.79619,272.363-504.017119.955-3,212.0342,128.92510,511.43644,031.431-697.596-661.893-479.438-436.287-448.24-3,139.5413,365.892451,857.483-97.296-609.526-1,557.858
Overige Informatie:
Effect van Wisselkoersveranderingen op Kas -7,118.109638.7311,678.684-2,030.1022,134.535-1,174.3941,835.549-3,164.3578,298.638-81.553-718.491-43.579-1,608.948-805.5498,043.334-8,670.29159.605289.80982.178
Netto Kasstroomverandering -21,131.806-35,121.5165,674.826-22,669.0221,617.667-20,266.875-146,697.07211,605.821-27,096.57410,079.708-3,483.49-128,764.297-55,174.031-33,092.891-3,453.604437,513.465-13,403.268-4,791.609-11,905.897
Kaspositie aan het Einde van de Periode 152,186.143173,317.949210,483.42241,389.92564,058.947104,578.895125,909.523272,606.595261,000.774288,097.348249,569.236253,052.726381,817.023436,991.054461,375.603464,829.20727,315.74240,719.0145,783.636